- Report
- June 2025
- 200 Pages
Europe
From €2229EUR$2,490USD£1,914GBP
- Report
- June 2025
- 200 Pages
Global
From €2229EUR$2,490USD£1,914GBP
- Report
- May 2025
- 120 Pages
Global
From €5327EUR$5,950USD£4,573GBP
- Report
- December 2024
- 150 Pages
Global
From €5327EUR$5,950USD£4,573GBP
- Report
- June 2024
- 140 Pages
Global
From €2238EUR$2,500USD£1,921GBP
- Report
- December 2023
- 176 Pages
Global
From €2238EUR$2,500USD£1,921GBP
- Report
- August 2025
- 193 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2023
- 88 Pages
Asia Pacific
From €3581EUR$4,000USD£3,074GBP
- Report
- December 2024
- 175 Pages
Global
From €4476EUR$5,000USD£3,843GBP
- Report
- February 2023
- 328 Pages
Global
From €4476EUR$5,000USD£3,843GBP
- Report
- May 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,190GBP
- Report
- May 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,190GBP
- Report
- January 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,190GBP
- Report
- October 2023
- 145 Pages
Global
From €2820EUR$3,150USD£2,421GBP
- Report
- July 2026
- 68 Pages
Canada
From €4252EUR$4,750USD£3,651GBP
- Report
- April 2026
- 81 Pages
Saudi Arabia
From €4252EUR$4,750USD£3,651GBP
- Report
- April 2026
- 85 Pages
Argentina
From €4252EUR$4,750USD£3,651GBP
- Report
- April 2026
- 80 Pages
Germany
From €4252EUR$4,750USD£3,651GBP
- Report
- April 2026
- 100 Pages
Spain
From €4252EUR$4,750USD£3,651GBP
- Report
- April 2026
- 68 Pages
Brazil
From €4252EUR$4,750USD£3,651GBP

The Ventricular Assist Device (VAD) market is a subset of the Cardiovascular Devices market. VADs are mechanical pumps that are implanted in the body to help the heart pump blood. They are used to treat heart failure, bridge patients to heart transplantation, and provide long-term support for patients with end-stage heart failure. VADs are typically used in patients who are not eligible for heart transplantation or who are waiting for a donor heart.
VADs are classified into two main categories: left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs). LVADs are used to support the left ventricle, while RVADs are used to support the right ventricle. Both types of VADs are designed to improve the quality of life of patients with heart failure.
Some companies in the VAD market include Abiomed, Medtronic, Thoratec, and SynCardia. Show Less Read more